Phase I trial of the combination of bortezomib and clofarabine in adults with refractory solid tumors.

被引：0
|
作者：
Coyne, Geraldine Helen O'Sullivan
Kummar, Shivaani
Khanh Tu Do
Holbeck, Susan
Hollingshead, Melinda G.
Horneffer, Yvonne
Juwara, Lamin
Srivastava, Apurva K.
Rubinstein, Larry
Piekarz, Richard
Sharon, Elad
Streicher, Howard
Conley, Barbara A.
Antony, Ramya
Collins, Jerry M.
Chen, Alice
Doroshow, James H.
机构：
[1] Early Clin Trials Dev Program, Bethesda, MD USA
[2] Stanford Univ, Sch Med, Phase Clin Res Program 1, Stanford, CA 94305 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] NCI, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA
[5] NCI, Div Canc Treatment & Diag, NIH, Frederick, MD 21701 USA
[6] NCI, Bethesda, MD 20892 USA
[7] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Frederick, MD USA
[8] Div Canc Treatment & Diag, Bethesda, MD USA
[9] NCI, Canc Therapy Evaluat Program, NIH, Bethesda, MD 20892 USA
[10] NCI, Div Canc Treatment & Diag, Bethesda, MD 20892 USA
[11] NCI, Rockville, MD USA
[12] Leidos Biomed Res Inc, Frederick, MD USA
[13] NCI, DCTD, Rockville, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS2614
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A phase I study of temsirolimus plus erlotinib in patients with refractory solid tumors.
    Wang-Gillam, Andrea
    Tan, Benjamin R.
    Waqar, Saiama Naheed
    Suresh, Rama
    Morgensztern, Daniel
    Van Tine, Brian Andrew
    Nieman, Rebecca
    Govindan, Ramaswamy
    Lockhart, Albert C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [32] Phase I trial of carboplatin, irinotecan and etoposide in advanced solid tumors.
    Chiappori, A
    Simon, GR
    Kvols, L
    Tetteh, L
    Mahany, JJ
    Lush, R
    Sullivan, DM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 160S - 160S
  • [33] Phase I trial of irinotecan and epirubicin in patients with advanced solid tumors.
    Gold, PJ
    Refice, S
    West, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 164S - 164S
  • [34] Phase I trial of sorafenib, bevacizumab, and temsirolimus in advanced solid tumors.
    Westin, Shannon Neville
    Smart, Melody L.
    Pal, Navdeep
    Urbauer, Diana L.
    Janku, Filip
    Wheler, Jennifer J.
    Piha-Paul, Sarina Anne
    Naing, Aung
    Tsimberidou, Apostolia Maria
    Fu, Siqing
    Falchook, Gerald Steven
    Hong, David S.
    Zinner, Ralph
    Subbiah, Vivek
    Culotta, Kirk Salvatore
    Lu, Karen H.
    Coleman, Robert L.
    Kurzrock, Razelle
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] A phase I trial of sarcosinamide nitrosourea in adult patients with solid tumors.
    Puchalski, TA
    Eder, JP
    Ryan, DP
    Clark, JW
    Castellana, W
    Garcia-Carbonero, R
    Kufe, DW
    Supko, JG
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3709S - 3709S
  • [36] Phase I trial of vinflunine and pemetrexed in refractory solid tumors
    Hanna K. Sanoff
    Janine Davies
    Christine Walko
    Larry Buie
    Wing-Keung Chiu
    Anastasia Ivanova
    Bert O’Neil
    Thomas E. Stinchcombe
    Kimberly Keller
    E. Claire Dees
    Investigational New Drugs, 2011, 29 : 131 - 136
  • [37] Phase I trial of vinflunine and pemetrexed in refractory solid tumors
    Sanoff, Hanna K.
    Davies, Janine
    Walko, Christine
    Buie, Larry
    Chiu, Wing-Keung
    Ivanova, Anastasia
    O'Neil, Bert
    Stinchcombe, Thomas E.
    Keller, Kimberly
    Dees, E. Claire
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (01) : 131 - 136
  • [38] Phase I trial of the epothilone B analog BMS-247550 (ixabepilone) in children with refractory solid tumors.
    Widemann, BC
    Fox, E
    Goodspeed, WJ
    Goodwin, A
    Cohen, M
    Fojo, T
    Colevas, AD
    Balis, FM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 807S - 807S
  • [39] Initial phase I trial of a new liposome-encapsulated doxorubicin formulation in patients with refractory solid tumors.
    Izquierdo, MA
    Balañá, C
    Fabregat, X
    García, M
    Martinez, M
    Llorens, MA
    Gimeno, M
    Mesia, R
    Rosell, R
    Germá, JR
    CLINICAL CANCER RESEARCH, 1999, 5 : 3795S - 3795S
  • [40] A phase I study of panobinostat in pediatric patients with refractory solid tumors, including CNS tumors.
    Wood, Paul James
    Strong, Robyn
    McArthur, Grant A.
    Michael, Michael
    Algar, Elizabeth
    Muscat, Andrea
    Rigby, Lin
    Ashley, David M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345